华峰化学(002064) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥6,191,508,828.17, a decrease of 15.10% compared to ¥7,292,744,819.49 in the same period last year[2] - Net profit attributable to shareholders was ¥631,434,595.14, down 53.65% from ¥1,362,312,276.49 year-on-year[2] - The company experienced a 54.26% decline in operating profit, amounting to ¥713,793,139.30, attributed to falling product prices[5] - The total profit for the period was ¥705,179,621.66, a decrease of 54.58% compared to ¥1,552,570,700.80 in the previous year[5] - Basic earnings per share decreased by 55.17% to ¥0.13 from ¥0.29 in the same period last year[2] - Operating profit for the current period is ¥713,793,139.30, down 54.4% from ¥1,560,613,961.53 in the previous period[13] - Net profit decreased to ¥630,506,336.71, a decline of 53.7% compared to ¥1,362,288,781.33 in the same period last year[13] - Total comprehensive income for the current period is ¥637,025,742.19, down 53.1% from ¥1,356,174,287.10 in the previous period[14] Cash Flow - The net cash flow from operating activities was ¥80,894,838.69, reflecting a decline of 61.18% compared to ¥208,376,548.19 in the previous year[2] - Cash flow from operating activities generated a net amount of ¥80,894,838.69, down from ¥208,376,548.19 in the previous period[15] - The net cash flow from investment activities was -408,755,952.38 CNY, compared to -606,350,985.71 CNY in the previous year, indicating an improvement[16] - The total cash inflow from financing activities was 1,373,809,627.45 CNY, down from 3,384,495,023.58 CNY year-over-year[16] - The net cash flow from financing activities was 645,334,369.00 CNY, significantly lower than 2,942,153,403.52 CNY in the same period last year[16] - The cash flow from operating activities was not detailed in the provided content, but the overall cash position improved with a net increase of 286,429,888.80 CNY[16] Assets and Liabilities - Total assets increased by 4.59% to ¥34,258,313,640.55 from ¥32,754,768,551.67 at the end of the previous year[2] - The total assets of the company reached approximately CNY 34.26 billion at the end of the first quarter, an increase from CNY 32.75 billion at the beginning of the year, reflecting a growth of about 4.6%[9] - Current assets totaled CNY 19.85 billion, up from CNY 18.67 billion, indicating an increase of approximately 6.3%[9] - Total liabilities amounted to CNY 10.47 billion, compared to CNY 9.61 billion previously, reflecting an increase of about 9.0%[11] - The company's short-term borrowings rose to CNY 2.93 billion, up from CNY 2.18 billion, marking an increase of approximately 34.3%[10] Investments and Equity - The company reported a significant increase in trading financial assets by 63.20% to ¥113,100,000.00 due to an increase in wealth management products[5] - The company's long-term equity investments increased to CNY 674.82 million, compared to CNY 650.02 million, reflecting a growth of approximately 3.8%[10] - The total equity attributable to shareholders reached CNY 23.79 billion, an increase from CNY 23.15 billion, indicating a growth of about 2.8%[11] Expenses - Research and development expenses were ¥217,324,135.83, a decrease of 29.4% from ¥308,016,885.57 in the previous period[13] - The company reported a tax expense of ¥74,673,284.95, significantly lower than ¥190,281,919.47 in the previous period[13] - Other income increased to ¥32,081,172.62 from ¥24,380,230.42, marking a growth of 31.5%[13] Inventory and Receivables - Inventory increased to CNY 3.12 billion, compared to CNY 2.84 billion at the beginning of the year, representing a growth of around 10.0%[9] - The company reported a significant increase in accounts receivable, which rose to CNY 2.72 billion from CNY 2.12 billion, a growth of about 28.2%[9] Audit Status - The report for the first quarter was not audited, as stated by the company's board[17]